RxDoctor Payments Data

Sarah Dietrich

Psychiatric/Mental Health · Covington, TNNPI 1396149951

Payments from drug & device makers

$1,161in general payments, 2019–2025

Across 61 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$329
  • Neurocrine Biosciences, Inc.$192
  • Teva Pharmaceuticals USA, Inc.$181
  • Otsuka America Pharmaceutical, Inc.$105
  • Vanda Pharmaceuticals Inc.$87
  • Johnson & Johnson$66
  • plus $200 from 7 others

What the payments were for

  • Food & beverage$1,11296%
  • Education$494%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,161 in reported general payments places this provider in the 60th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$11,371
Medicare patients
29
Services billed
221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate56$188,753
AustedoDeutetrabenazine31$177,393
AristadaAripiprazole Lauroxil19$53,383
RexultiBrexpiprazole12$24,966
TrintellixVortioxetine Hydrobromide40$18,882
Paliperidone ErPaliperidone70$11,108
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl63$10,306
Lurasidone Hcl35$6,153
Divalproex Sodium ErDivalproex Sodium58$2,281
Clozapine25$2,236
Ziprasidone Hcl34$2,144
Aripiprazole110$1,819
Haloperidol58$1,770
Buspirone Hcl102$1,436
Duloxetine Hcl74$1,392

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$66$188,75356 claims
Teva Pharmaceuticals USA, Inc.Austedo$181$177,39331 claims
Alkermes, Inc.Aristada$329$53,38319 claims
Otsuka America Pharmaceutical, Inc.Rexulti$105$24,96612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Covington

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →